Research institutions
Mechanistic studies, neural-repair models, remyelination biology, biomarkers and translational research.
Partnering
Partner with Maak across research, development and growth.
Maak works with organisations that can advance proprietary programmes, execute specialist development work or expand biotechnology activity from Oman.
Partnership areas
Four routes to work
with Maak.
Engagements are built around a defined programme, capability or commercial objective.
Manufacturing & analytics
Peptide synthesis, CMC, advanced analytical methods, stability, batch documentation and specialist testing.
Translational development
Nonclinical programmes, pharmacology, bioanalysis, imaging, electrophysiology and quantitative functional endpoints.
Strategic capital & licensing
Asset financing, co-development, regional commercial partnerships and licensing discussions.
What Maak brings
A focused programme owner with a base in Oman.
Maak combines proprietary neural-repair research with practical experience in peptide project definition, international provider coordination, technical documentation and commercial development.
Current priorities
Relationships that move programmes forward.
Current scientific priorities include proteoglycan and PTPσ biology, neurite-outgrowth models, remyelination, cellular neurobiology, biomarkers and specialist nonclinical development.
Maak also welcomes institutional and investment discussions connected to the company's Oman headquarters, IPM facility plan and regional biotechnology growth.
Start a discussion